Drugs for treatment of very high blood pressure during pregnancy (Q24200974)

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Digoxin immune fab treatment for severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Improving placental blood flow in pre‐eclampsia with prostaglandin A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A new treatment of severe pre-eclampsia by long-term epidural anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Long-term treatment with nicardipine for severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Hyperuricaemia and preeclampsia: is there a pathogenic link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

The optimal dosage of ketanserin for patients with severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Interventionist versus expectant care for severe pre-eclampsia before term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Plasma volume expansion for treatment of women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Interventions for treating pre-eclampsia and its consequences: generic protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Guidelines for the management of hypertensive disorders of pregnancy 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

The two stage model of preeclampsia: variations on the theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Drugs for treatment of very high blood pressure during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Drugs for treatment of very high blood pressure during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB3

A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy

21 January 2018

1 reference

12 December 2020

[Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]

1 reference

12 December 2020

Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial

1 reference

12 December 2020

Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment

1 reference

12 December 2020

A CONTROLLED CLINICAL TRIAL OF GUANETHIDINE IN TOXEMIA OF PREGNANCY

1 reference

12 December 2020

Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.

1 reference

12 December 2020

Efficacy of AT in pre-eclampsia: a case-control prospective trial.

1 reference

12 December 2020

Nifedipine in the treatment of severe preeclampsia

1 reference

12 December 2020

Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome

1 reference

12 December 2020

Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil

1 reference

12 December 2020

A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy

1 reference

12 December 2020

[Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia]

1 reference

12 December 2020

Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy

1 reference

12 December 2020

Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol

1 reference

12 December 2020

Oral nifedipine therapy in the management of severe preeclampsia.

1 reference

12 December 2020

Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial

1 reference

12 December 2020

Magnesium sulphate and other anticonvulsants for women with pre-eclampsia

1 reference

12 December 2020

Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy

1 reference

12 December 2020

OS014. Which first-line drug to control severe hypertension in pregnancy? A pilot study.

1 reference

12 December 2020

Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip--a comparative study

1 reference

12 December 2020

The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension

1 reference

12 December 2020

Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared

1 reference

12 December 2020

Magnesium sulphate versus lytic cocktail for eclampsia

1 reference

12 December 2020

PP087. Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women

1 reference

12 December 2020

Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial

1 reference

12 December 2020

[The effect of Nifedipine on postpartum blood loss in patients with pregnancy induced hypertension]

1 reference

12 December 2020

Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice

1 reference

12 December 2020

New therapeutics alternative in severe preeclampsia

1 reference

12 December 2020

Low-dose diazoxide in the emergency management of severe hypertension in pregnancy.

1 reference

12 December 2020

The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.

1 reference

12 December 2020

Nifedipine in acute hypertensive emergencies in pregnancy.

1 reference

12 December 2020

Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia

1 reference

12 December 2020

Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results

1 reference

12 December 2020

Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy

1 reference

12 December 2020

Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study

1 reference

12 December 2020

A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy

1 reference

12 December 2020

Hypertension in pregnancy

1 reference

12 December 2020

Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group

1 reference

12 December 2020

Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.

1 reference

12 December 2020

Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom

1 reference

12 December 2020

Phosphodiesterase Inhibitor Effect on Small Artery Function in Preeclampsia

1 reference

12 December 2020

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia

1 reference

12 December 2020

Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial

1 reference

12 December 2020